NDC 69539-023

Deferasirox

Deferasirox

Deferasirox is a Oral Tablet, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Msn Laboratories Private Limited. The primary component is Deferasirox.

Product ID69539-023_4b237031-5375-4a5a-8a5d-21527f6fc7da
NDC69539-023
Product TypeHuman Prescription Drug
Proprietary NameDeferasirox
Generic NameDeferasirox
Dosage FormTablet, For Suspension
Route of AdministrationORAL
Marketing Start Date2019-11-20
Marketing CategoryANDA / ANDA
Application NumberANDA209878
Labeler NameMSN LABORATORIES PRIVATE LIMITED
Substance NameDEFERASIROX
Active Ingredient Strength500 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 69539-023-05

500 TABLET, FOR SUSPENSION in 1 BOTTLE (69539-023-05)
Marketing Start Date2019-11-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69539-023-05 [69539002305]

Deferasirox TABLET, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA209878
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-20

NDC 69539-023-90 [69539002390]

Deferasirox TABLET, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA209878
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-20

NDC 69539-023-30 [69539002330]

Deferasirox TABLET, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA209878
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-20

Drug Details

Active Ingredients

IngredientStrength
DEFERASIROX500 mg/1

Pharmacological Class

  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inhibitors [MoA]

NDC Crossover Matching brand name "Deferasirox" or generic name "Deferasirox"

NDCBrand NameGeneric Name
45963-454DeferasiroxDeferasirox
45963-456DeferasiroxDeferasirox
45963-455DeferasiroxDeferasirox
46708-326DeferasiroxDeferasirox
46708-410DEFERASIROXDEFERASIROX
46708-325DeferasiroxDeferasirox
46708-324DeferasiroxDeferasirox
46708-412DEFERASIROXDEFERASIROX
62332-326DeferasiroxDeferasirox
62332-324DeferasiroxDeferasirox
62332-325DeferasiroxDeferasirox
62332-410DEFERASIROXDEFERASIROX
62332-412DEFERASIROXDEFERASIROX
67877-551DeferasiroxDeferasirox
67877-550DeferasiroxDeferasirox
67877-549DeferasiroxDeferasirox
69539-023DeferasiroxDeferasirox
69539-073DeferasiroxDeferasirox
69539-022DeferasiroxDeferasirox
69539-075DeferasiroxDeferasirox
69539-021DeferasiroxDeferasirox
70710-1277deferasiroxdeferasirox
70710-1275deferasiroxdeferasirox
43598-851DeferasiroxDeferasirox
43598-855DeferasiroxDeferasirox
43598-856DeferasiroxDeferasirox
43598-853DeferasiroxDeferasirox
43598-854DeferasiroxDeferasirox
62756-569deferasiroxdeferasirox
62756-570deferasiroxdeferasirox
62756-568deferasiroxdeferasirox
69452-159DeferasiroxDeferasirox
69452-161DeferasiroxDeferasirox
69452-160DeferasiroxDeferasirox
70771-1471deferasiroxdeferasirox
70771-1473deferasiroxdeferasirox
0093-3515DeferasiroxDeferasirox
0093-3517DeferasiroxDeferasirox
0591-3853DeferasiroxDeferasirox
16714-995deferasiroxdeferasirox
16714-993deferasiroxdeferasirox
0078-0468Exjadedeferasirox
0078-0469Exjadedeferasirox
0078-0470Exjadedeferasirox
0078-0654Jadenudeferasirox
0078-0655Jadenudeferasirox
0078-0656Jadenudeferasirox

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.